Carlyle strikes $3.8bn deal for Baxter’s kidney care segment

Carlyle strikes $3.8bn deal for Baxter’s kidney care segment

Global investment firm Carlyle has agreed to acquire US medtech company Baxter International’s kidney care segment — to be named Vantive — for $3.8bn, concluding talks initially reported by Reuters and the Wall Street Journal last month. The transaction is expected to...
KKR plans $4bn Fuji Soft take-private deal

KKR plans $4bn Fuji Soft take-private deal

US private equity major KKR is planning to take Japanese systems developer Fuji Soft private in a deal valued at around JPY600bn ($4.13bn), according to a report by NikkeiAsia citing unnamed sources familiar with the matter. The move comes amid pressure from Fuji...
EQT eyes $12.5bn for new Asia fund

EQT eyes $12.5bn for new Asia fund

Swedish investment firm EQT, Europe’s largest private equity house with over €200bn in assets under management, is looking to raise $12.5bn for a new fund which will focus on investments in the Asian market, according to a report by Reuters. The fund, named EQT...